Cytosorbents Corp
CTSO
48 hedge funds and large institutions have $16.7M invested in Cytosorbents Corp in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 13 increasing their positions, 16 reducing their positions, and 6 closing their positions.
4.37% less ownership
Funds ownership: 38.06% → 33.69% (-4.4%)
8% less funds holding
Funds holding: 52 → 48 (-4)
19% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 16
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
75% less capital inflows, than outflows
Capital inflows: $737K | Capital outflows: $2.98M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CM
CM Management
Gulf Breeze,
Florida
|
+$399K |
| 2 |
Avenir Corporation
Alexandria,
Virginia
|
+$118K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$71.4K |
| 4 |
Sargent Investment Group
Bethesda,
Maryland
|
+$56K |
| 5 |
Jane Street
New York
|
+$45.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Neuberger Berman Group
New York
|
-$1.65M |
| 2 |
Granahan Investment Management
Waltham,
Massachusetts
|
-$558K |
| 3 |
Skylands Capital
Milwaukee,
Wisconsin
|
-$369K |
| 4 |
Renaissance Technologies
New York
|
-$93.1K |
| 5 |
Ledgewood Wealth Advisors
Exeter,
New Hampshire
|
-$81K |
CTSO Hedge Fund Activity: Q1 2024 in Review
48 of the 6,966 institutional investors tracked by Wall St. Rank reported a position in Cytosorbents Corp (CTSO) for Q1 2024, worth a combined $16.7M — down 24% from $22M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of CTSO and 2 opened new positions — a net loss of 4 holders — while 16 trimmed existing stakes and 13 added.
The largest buyer was CM Management, adding an estimated $399K. The largest seller was Neuberger Berman Group, cutting an estimated $1.65M.
- 48 institutional investors held Cytosorbents Corp (CTSO) as of Q1 2024, down from 52 in Q4 2023.
- Funds reported $16.7M of Cytosorbents Corp stock for Q1 2024, down 24% quarter-over-quarter.
- 2 funds opened new Cytosorbents Corp positions in Q1 2024 and 6 closed out, a net change of -4 holders.
- The largest Cytosorbents Corp buyer in Q1 2024 was CM Management, an estimated $399K added.
- The largest Cytosorbents Corp seller in Q1 2024 was Neuberger Berman Group, an estimated $1.65M sold.
Based on aggregated 13F filings for Q1 2024.